Quantification of the functional expression of the Ca2+-activated K+ channel KCa3.1 on microglia from adult human neocortical tissue

GLIA

Volumn 64, Issue 12, 2016, Pages 2065-2078

  Blomster, Linda V ^a,b   Strøbæk, Dorte ^a   Hougaard, Charlotte ^a   Klein, Jessica ^a   Pinborg, Lars H ^b   Mikkelsen, Jens D ^b   Christophersen, Palle ^a  

^a Saniona AB   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

BK channel; glial cell; IK channel; neuroinflammation; patch clamp; potassium channel

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 4 [[3 (TRIFLUOROMETHYL)PHENYL]METHYL] 2H 1,4 BENZOTHIAZIN 3(4H) ONE; 6,7 DICHLORO 1H INDOLE 2,3 IONE 3 OXIME; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL KCA3.1; INTERLEUKIN 4; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; LIPOPOLYSACCHARIDE; PAXILLINE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; 6,7-DICHLORO-1H-INDOLE-2,3-DIONE 3-OXIME; BENZIMIDAZOLE DERIVATIVE; CYTOKINE; INDOLE DERIVATIVE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNN4 PROTEIN, HUMAN; NERVE PROTEIN; OXIME;

ADULT; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DEPOLARIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROGLIA; NEOCORTEX; NERVE CELL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHOLE CELL PATCH CLAMP; DOSE RESPONSE; DRUG EFFECTS; EPILEPSY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MEMBRANE POTENTIAL; METABOLISM; PATCH CLAMP TECHNIQUE; PATHOLOGY; TIME FACTOR;

BENZIMIDAZOLES; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INDOLES; INTERLEUKIN-4; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LIPOPOLYSACCHARIDES; MALE; MEMBRANE POTENTIALS; MICROGLIA; NEOCORTEX; NERVE TISSUE PROTEINS; OXIMES; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; TIME FACTORS;

EID: 84979752418     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.23040     Document Type: Article

References (38)

1. + currents in microglia from human hippocampi. Eur J Neurosci 18:2893–2898.
2. + channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury. J Neurosci 31:16298–16308.
3. Chen YJ, Nguyen HM, Maezawa I, Grossinger EM, Garing AL, Kohler R, Jin LW, Wulff H. 2015. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke. J Cereb Blood Flow Metab pii:0271678X15611434.
4. Chen YJ, Raman G, Bodendiek S, O'Donnell ME, Wulff H. 2011. The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke. J Cereb Blood Flow Metab 31:2363–2374.
5. + channel from human erythrocyte membranes: Single channel rectification and selectivity. J Membr Biol 119:75–83.
6. Ferreira R, Lively S, Schlichter LC. 2014. IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia. Front Cell Neurosci 8:183-
7. Ferreira R, Wong R, Schlichter LC. 2015. KCa3.1/IK1 channel regulation by cGMP-dependent protein kinase (PKG) via reactive oxygen species and CaMKII in microglia: An immune modulating feedback system? Front Immunol 6:153-
8. Fordyce CB, Jagasia R, Zhu X, Schlichter LC. 2005. Microglia Kv1.3 channels contribute to their ability to kill neurons. J Neurosci 25:7139–7149.
9. Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA, Cahalan MD, Chandy KG. 2000. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 275:37137–37149.
10. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J. 1997. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 94:11651–11656.
11. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320–4330.
12. Jenkins DP, Yu W, Brown BM, Lojkner LD, Wulff H. 2013. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators. Assay Drug Dev Technol 11:551–560.
13. + channel. Am J Physiol 275:C848–C856.
14. +-influx assay. Assay Drug Dev Technol 11:163–172.
15. + channels in activated microglia in vivo. Glia 24:408–414.
16. Kang H, Kerloc'h A, Rotival M, Xu X, Zhang Q, D'Souza Z, Kim M, Scholz JC, Ko JH, Srivastava PK, Genzen JR, Cui W, Aitman TJ, Game L, Melvin JE, Hanidu A, Dimock J, Zheng J, Souza D, Behera AK, Nabozny G, Cook HT, Bassett JH, Williams GR, Li J, Vignery A, Petretto E, Behmoaras J. 2014. Kcnn4 is a regulator of macrophage multinucleation in bone homeostasis and inflammatory disease. Cell Rep 8:1210–1224.
17. + channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. J Neurosci 27:234–244.
18. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461–553.
19. + channels and the microglial respiratory burst. Am J Physiol Cell Physiol 280:C796–C806.
20. Knaus HG, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LM, Sanchez M, Giangiacomo K, Reuben JP, Smith AB III, Kaczorowski GJ, Garcia ML. 1994. Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry 33:5819–5828.
21. Maezawa I, Zimin PI, Wulff H, Jin LW. 2011. Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J Biol Chem 286:3693–3706.
22. Mauler F, Hinz V, Horvath E, Schuhmacher J, Hofmann HA, Wirtz S, Hahn MG, Urbahns K. 2004. Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma. Eur J Neurosci 20:1761–1768.
23. McLarnon JG, Xu R, Lee YB, Kim SU. 1997. Ion channels of human microglia in culture. Neuroscience 78:1217–1228.
24. Michell-Robinson MA, Touil H, Healy LM, Owen DR, Durafourt BA, Bar-Or A, Antel JP, Moore CS. 2015. Roles of microglia in brain development, tissue maintenance and repair. Brain 138:1138–1159.
25. Nhu QM, Shirey K, Teijaro JR, Farber DL, Netzel-Arnett S, Antalis TM, Fasano A, Vogel SN. 2010. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol 3:29–39.
26. Norenberg W, Illes P, Gebicke-Haerter PJ. 1994. Sodium channel in isolated human brain macrophages (microglia). Glia 10:165–172.
27. Olesen S-P, Waetjen F; Neurosearch A/S, assignee. 1993. Benzimidazole derivatives, their preparation and use. Patent US5200422 A.
28. + channels by novel benzimidazolone. Eur J Pharmacol 251:53–59.
29. Reich EP, Cui L, Yang L, Pugliese-Sivo C, Golovko A, Petro M, Vassileva G, Chu I, Nomeir AA, Zhang LK, Liang X, Kozlowski JA, Narula SK, Zavodny PJ, Chou CC. 2005. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur J Immunol 35:1027–1036.
30. Sauve R, Simoneau C, Monette R, Roy G. 1986. Single-channel analysis of the potassium permeability in HeLa cancer cells: Evidence for a calcium-activated potassium channel of small unitary conductance. J Membr Biol 92:269–282.
31. 2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro. J Neuroinflammation 7:4.
32. Siddiqui T, Lively S, Ferreira R, Wong R, Schlichter LC. 2014. Expression and contributions of TRPM7 and KCa2.3/SK3 channels to the increased migration and invasion of microglia in anti-inflammatory activation states. PLoS One 9:e106087.
33. Smith AM, Dragunow M. 2014. The human side of microglia. Trends Neurosci 37:125–135.
34. Strobaek D, Brown DT, Jenkins DP, Chen YJ, Coleman N, Ando Y, Chiu P, Jorgensen S, Demnitz J, Wulff H, Christophersen P. 2013. NS6180, a new K(Ca) 3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease. Br J Pharmacol 168:432–444.
35. + channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). Biochim Biophys Acta 1665:1–5.
36. Urbahns K, Horvath E, Stasch JP, Mauler F. 2003. 4-Phenyl-4H-pyrans as IK(Ca) channel blockers. Bioorg Med Chem Lett 13:2637–2639.
37. 2+ signaling, which requires Ser332/334 in the CaM-binding C terminus. J Neurosci 34:13371–13383.
38. + channel expression during B cell differentiation: Implications for immunomodulation and autoimmunity. J Immunol 173:776–786.